We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Oak Street Health, Inc. (“Oak Street” or the “Company”) (NYSE: OSH), in connection with the proposed acquisition of the Company by CVS Health Corporation (NYSE: CVS).  Under the terms of the merger agreement, the Company’s shareholders will receive $39.00 in cash for each share of Oak Street common stock owned.  The transaction is valued at approximately $10.6 billion.

Weiss Law is investigating whether (i) Oak Street’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the $39.00 per share merger consideration adequately compensates Oak Street’s shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.  Notably, at least one analyst set a price target for the Company of $47 per share, $8.00 above the per-share merger consideration.